The Skill to Heal. The Heart to Care.

Phone: 505.842.8171

dotAfter Hours: 505.857.3877

dotPharmacy: 505.822.3911

Current NMCC Clinical Trials

RTOG 1205: Randomized Phase II Trial of Concurrent Bevacizumab and Re-irradiation versus Bevacizumab alone as Treatment for Recurrent Glioblastoma

Amgen 20110148: Randomized, single blind study to estimate the effect of patient education on reported bone pain in Breast Cancer patients receiving chemotherapy and Pegfilgrastim

Pfizer B3271002: A Phase 3 Randomized, Double-Blind Study of PF-05280014 Plus Paclitaxel Versus Trastuzumab Plus Paclitaxel for the First-Line Treatment of Patients With HER2-Positive Metastatic Breast Cancer

Celgene CONNECT: The (MDS) Myelodysplastic Syndromes and (AML) Acute Myeloid Leukemia Disease Registry

Synta : A randomized, phase 3 study of Ganetespib in combination with docetaxel versus docetaxel alone in patients with advanced Non-Small-Cell Lung adenocarcinoma

Multiple Myeloma
Multiple Myeloma: Millennium- A Phase 3, Randomized, Double-blind, Multicenter Study Comparing Oral MLN9708 Plus Lenalidomide and Dexamethasone Versus Placebo Plus Lenalidomide and Dexamethasone in Adult Patients with Newly Diagnosed Multiple Myeloma

RTOGĀ  0534: A Phase III Trial Of Short Term Androgen Deprivation With Pelvic Lymph Node Or Prostate Bed Only Radiotherapy (SPPORT) In Prostate Cancer Patients with A Rising PSA After Radical Prostatectomy

Supportive Care
WEX TTX-CINP-201: Double-blind, dose-finding, placebo controlled, multicenter study of Tetrodotoxin in the treatment of chemotherapy induced neuropathic pain